Preoperative Selective Desensitization of Live Donor Liver Transplant Recipients Considering the Degree of T Lymphocyte Cross-Match Titer, Model for End-Stage Liver Disease Score, and Graft Liver Volume
Open Access
- 1 January 2014
- journal article
- Published by XMLink in Journal of Korean Medical Science
- Vol. 29 (5) , 640-7
Abstract
Several studies have suggested that a positive lymphocyte cross-matching (XM) is associated with low graft survival rates and a high prevalence of acute rejection after adult living donor liver transplantations (ALDLTs) using a small-for-size graft. However, there is still no consensus on preoperative desensitization. We adopted the desensitization protocol from ABO-incompatible LDLT. We performed desensitization for the selected patients according to the degree of T lymphocyte cross-match titer, model for end-stage liver disease (MELD) score, and graft liver volume. We retrospectively evaluated 230 consecutive ALDLT recipients for 5 yr. Eleven recipients (4.8%) showed a positive XM. Among them, five patients with the high titer (> 1:16) by antihuman globulin-augmented method (T-AHG) and one with a low titer but a high MELD score of 36 were selected for desensitization: rituximab injection and plasmapheresis before the transplantation. There were no major side effects of desensitization. Four of the patients showed successful depletion of the T-AHG titer. There was no mortality and hyperacute rejection in lymphocyte XM-positive patients, showing no significant difference in survival outcome between two groups (P=1.000). In conclusion, this desensitization protocol for the selected recipients considering the degree of T lymphocyte cross-match titer, MELD score, and graft liver volume is feasible and safe.Keywords
Funding Information
- SNUH Research Fund (04-2011-1100)
This publication has 34 references indexed in Scilit:
- Understanding crossmatch testing in organ transplantation: A case‐based guide for the general nephrologistNephrology, 2011
- Does a positive lymphocyte cross-match contraindicate living-donor liver transplantation?Surgery, 2010
- Human leukocyte antigen crossmatch testing is important for liver retransplantationLiver Transplantation, 2010
- Successful Renal Transplantation with Desensitization in Highly Sensitized Patients: A Single Center ExperienceJournal of Korean Medical Science, 2009
- The Risk Factors of Acute Cellular Rejection in Adult Living Donor Liver Transplantation: Doubting the Value of Positive Lymphocytotoxic Cross-match ResultsThe Journal of the Korean Society for Transplantation, 2009
- Positive Lymphocytotoxic Crossmatch Does Not Adversely Affect Survival in Living Donor Liver TransplantationDigestive Surgery, 2009
- Antidonor Antibody in Patients Receiving ABO-Identical and HLA-Mismatched Living Donor Liver Transplants: Effect on SurvivalTransplantation, 2007
- Influence of HLA compatibility and lymphocyte cross‐matching on acute cellular rejection following living donor adult liver transplantationLiver International, 2005
- Significance of positive cytotoxic cross-match in adult-to-adult living donor liver transplantation using small graft volumeLiver Transplantation, 2002
- EVIDENCE FOR AN IMMUNE RESPONSE TO HLA CLASS I ANTIGENS IN THE VANISHING-BILEDUCT SYNDROME AFTER LIVER TRANSPLANTATIONThe Lancet, 1987